proline has been researched along with Atrioventricular Nodal Re-Entrant Tachycardia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butera, JA; Di, L; Hennan, JK; Huselton, C; Larsen, BD; Morgan, GA; Piatnitski Chekler, EL; Rossman, EI; Swillo, RE | 1 |
| Butera, J; Gardell, SJ; Hennan, JK; Kantrowitz, J; Morgan, GA; Petersen, JS; Rossman, EI; Swillo, RE; Vlasuk, GP | 1 |
2 other study(ies) available for proline and Atrioventricular Nodal Re-Entrant Tachycardia
| Article | Year |
|---|---|
Discovery of a class of potent gap-junction modifiers as novel antiarrhythmic agents.
Topics: Administration, Oral; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Benzamides; Disease Models, Animal; Dogs; Drug Discovery; Gap Junctions; Mice; Proline; Rats; Structure-Activity Relationship; Tachycardia, Ventricular | 2009 |
GAP-134 ([2S,4R]-1-[2-aminoacetyl]4-benzamidopyrrolidine-2-carboxylic acid) prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia/reperfusion injury in open-chest dogs.
Topics: Animals; Anti-Arrhythmia Agents; Benzamides; Coronary Circulation; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Infusions, Intravenous; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Proline; Tachycardia, Ventricular; Time Factors; Ventricular Premature Complexes | 2009 |